These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 25955017)
41. Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B. Liu P; Qi M; Ma C; Lao G; Liu Y; Liu Y; Liu Y FEBS Lett; 2013 Aug; 587(16):2523-9. PubMed ID: 23769985 [TBL] [Abstract][Full Text] [Related]
42. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489 [TBL] [Abstract][Full Text] [Related]
43. Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer. Okato A; Goto Y; Kurozumi A; Kato M; Kojima S; Matsushita R; Yonemori M; Miyamoto K; Ichikawa T; Seki N Int J Oncol; 2016 Jul; 49(1):111-22. PubMed ID: 27212625 [TBL] [Abstract][Full Text] [Related]
44. The functional significance of miR-1 and miR-133a in renal cell carcinoma. Kawakami K; Enokida H; Chiyomaru T; Tatarano S; Yoshino H; Kagara I; Gotanda T; Tachiwada T; Nishiyama K; Nohata N; Seki N; Nakagawa M Eur J Cancer; 2012 Apr; 48(6):827-36. PubMed ID: 21745735 [TBL] [Abstract][Full Text] [Related]
45. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275 [TBL] [Abstract][Full Text] [Related]
46. Functional significance of aberrantly expressed microRNAs in prostate cancer. Goto Y; Kurozumi A; Enokida H; Ichikawa T; Seki N Int J Urol; 2015 Mar; 22(3):242-52. PubMed ID: 25599923 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Xu X; Chen Z; Zhao X; Wang J; Ding D; Wang Z; Tan F; Tan X; Zhou F; Sun J; Sun N; Gao Y; Shao K; Li N; Qiu B; He J Biochem Biophys Res Commun; 2012 May; 421(4):640-5. PubMed ID: 22450326 [TBL] [Abstract][Full Text] [Related]
48. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Yoshino H; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Nishiyama K; Nohata N; Seki N; Nakagawa M Br J Cancer; 2011 Mar; 104(5):808-18. PubMed ID: 21304530 [TBL] [Abstract][Full Text] [Related]
49. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Tatarano S; Chiyomaru T; Kawakami K; Enokida H; Yoshino H; Hidaka H; Yamasaki T; Kawahara K; Nishiyama K; Seki N; Nakagawa M Int J Oncol; 2011 Jul; 39(1):13-21. PubMed ID: 21519788 [TBL] [Abstract][Full Text] [Related]
50. eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑β1‑induced epithelial‑mesenchymal transition. Zhang HH; Li R; Li YJ; Yu XX; Sun QN; Li AY; Kong Y Oncol Rep; 2020 Feb; 43(2):447-460. PubMed ID: 31894279 [TBL] [Abstract][Full Text] [Related]
51. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. Wang Y; Zhang S Biomed Pharmacother; 2018 Jul; 103():1287-1293. PubMed ID: 29864910 [TBL] [Abstract][Full Text] [Related]
52. Estrogen‑related receptor γ promotes the migration and metastasis of endometrial cancer cells by targeting S100A4. Hua T; Wang X; Chi S; Liu Y; Feng D; Zhao Y; Wang H Oncol Rep; 2018 Aug; 40(2):823-832. PubMed ID: 29901152 [TBL] [Abstract][Full Text] [Related]
53. Downregulation of glucose‑6‑phosphate dehydrogenase by microRNA‑1 inhibits the growth of pituitary tumor cells. He C; Yang J; Ding J; Li S; Wu H; Xiong Y; Zhou F; Jiang Y; Teng L; Yang J Oncol Rep; 2018 Dec; 40(6):3533-3542. PubMed ID: 30272333 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Konno Y; Dong P; Xiong Y; Suzuki F; Lu J; Cai M; Watari H; Mitamura T; Hosaka M; Hanley SJ; Kudo M; Sakuragi N Oncotarget; 2014 Aug; 5(15):6049-62. PubMed ID: 25153722 [TBL] [Abstract][Full Text] [Related]
56. microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Nohata N; Hanazawa T; Enokida H; Seki N Oncotarget; 2012 Jan; 3(1):9-21. PubMed ID: 22308266 [TBL] [Abstract][Full Text] [Related]
57. The expression of MMP-14 and microRNA-410 in FFPE tissues of human endometrial adenocarcinoma. Rak B; Garbicz F; Paskal W; Pełka K; Marczewska JM; Wołosz D; Włodarski P Histol Histopathol; 2016 Aug; 31(8):911-20. PubMed ID: 26842619 [TBL] [Abstract][Full Text] [Related]
59. Asparanin A inhibits cell migration and invasion in human endometrial cancer via Ras/ERK/MAPK pathway. Zhang F; Ni ZJ; Ye L; Zhang YY; Thakur K; Cespedes-Acuña CL; Han J; Zhang JG; Wei ZJ Food Chem Toxicol; 2021 Apr; 150():112036. PubMed ID: 33561516 [TBL] [Abstract][Full Text] [Related]
60. Upregulation of sperm-associated antigen 5 expression in endometrial carcinoma was associated with poor prognosis and immune dysregulation, and promoted cell migration and invasion. Chen M; Wang D; Xu Y; Yang C Sci Rep; 2024 Jun; 14(1):13415. PubMed ID: 38862557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]